P170: The impact of BC 007 on immune dysregulation in patients with Post-COVID syndrome
FAU own research funding: EFI / IZKF / EAM ...
Start date : 01.02.2025
End date : 31.08.2025
Project details
Scientific Abstract
In a subgroup of patients with Post-COVID Syndrom (PCS), functional autoantibodies against G protein-coupled receptors (GPCR-fAAbs) occur. We would like to characterise changes in the immune cell compartment of these patients, as we have seen changes of certain immune cells in preliminary experiments. Furthermore, we seek to analyse the effect of the substance BC 007, which can neutralize GPCR-fAAbs, in ex-vivo and in-vitro experiments.
Involved:
Contributing FAU Organisations:
Interdisziplinäres Zentrum für Klinische Forschung (IZKF)
Department of Medicine 3 – Rheumatology and Immunology
